<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">
  <title>PolyQ - SCA6</title>
  <link rel="shortcut icon" href="../../Images/image1.ico">
  <link rel="stylesheet" href="../../CSS/DiseasePages/disease_style_1.css">
  <link rel="stylesheet" href="highlight-js/highlightjs.css">
  <link rel="stylesheet" href="ScrollSpy.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.1.1/css/all.min.css" integrity="sha512-KfkfwYDsLkIlwQp6LFnl8zNdLGxu9YAA1QvwINks4PhcElQSvqcyVLLD9aMhXd13uQjoXtEKNosOWaZqXgel0g==" crossorigin="anonymous" referrerpolicy="no-referrer" />
  <link rel="stylesheet" href="../../CSS/DiseasePages/int-image.css">
</head>
<body>
  <script src="ScrollSpy.min.js"></script>
  <script src="highlight-js/highlight.pack.js"></script>
    <header>
      <a href=""><img class="abcri-logo" src="../../Images/Logo_ABCRI.png"></a>
      <a><img class="mngt-logo" src="../../Images/Logo_MNGT.png"></a>
      <h1> <strong>A ABC Research Institute polyglutamine disease database</strong></h1>
    </header>
  <nav>
    <img class="poly-logo" src="../../Images/logo-plyq.png"/>
    <ul>
      <li><a href="Huntington.html">HD</a></li>
      <li><a href="DRPLA.html">DRPLA</a></li>
      <li><a href="SBMA.html">SBMA</a></li>
    </ul>
      <div class="dropdown">
        <button onclick="myFunction()" class="dropbtn">More <i class="fa-solid fa-caret-down"></i></button>
        <div class="dropdown-content" id="myDropdown">
          <a href="SCA1.html">SCA1</a>
          <a href="SCA2.html">SCA2</a>
          <a href="SCA3.html">SCA3</a>
          <a href="SCA7.html">SCA7</a>
          <a href="SCA17.html">SCA17</a>
        </div>
      </div>
      <div class="dropdown-little">
        <button onclick="myFunctionLittle()" class="dropbtn-little">Other Diseases &nbsp <i class="fa-solid fa-turn-down"></i></button>
        <div class="dropdown-content-little" id="myDropdownLittle">
          <a href="Huntington.html">HD</a>
          <a href="DRPLA.html">DRPLA</a>
          <a href="SBMA.html">SBMA</a>
          <a href="SCA1.html">SCA1</a>
          <a href="SCA2.html">SCA2</a>
          <a href="SCA3.html">SCA3</a>
          <a href="SCA7.html">SCA7</a>
          <a href="SCA17.html">SCA17</a>
        </div>
      </div>
    <a href="../home.html" class="return-button"><i class="fa-solid fa-house"></i> Return to Home page </a>
    <a href="../home.html" class="return-little"><i class="fa-solid fa-house"></i> Home </a>
  </nav>
  <main>
    <div class="aside-bar-left">
      <h3> Page navigation</h3>
      <div id="indicator"></div>
    </div>
    <div class="text">
    <h1><a href="SCA6.html"><i class="fa-solid fa-caret-right"></i> &nbspSpinocerebellar Ataxia 6</a></h1>
    <section class="scrollspy" spy-title="Introduction">
      <div class="intro-section">
        <h2> Introduction </h2>
        <p>
          Spinocerebellar ataxia type 6 (SCA6) is one of the autosomal dominant cerebellar ataxias (ADCAs), and its main clinical feature is slowly progressive ataxia consistent with ADCA type III, namely, pure cerebellar ataxia. SCA6 is caused by a defect in a gene that makes a subunit of a voltage gated channel, involved in several processes, including calcium ion import. The genetic defect in this protein results in degeneration of primarily Purkinje cells of the cerebellum.
        </p>
        <p>
          SCA6 is an autosomal dominant disease, which means that individuals of either sex are equally likely to inherit the gene and develop the disease, and that passes directly from one generation to the next without skipping generations. Each child of a person with SCA6 (heterozygous) has a 50 percent chance of inheriting the gene that causes SCA6.
        </p>
      </div>
    </section>
    <section class="scrollspy" spy-title="First described">
      <div class="firstd-section">
      <h2> First Described</h2>
      <p>
        In 1997, an article correlated SCA6 with a polymorphic CAG repeat in the human α1A voltage-dependent calcium channel subunit. It was the first time Spinocerebellar ataxia type 6 has been reported to be associated with triplet repeats in the CACNA1A gene <span class="refbig"><a href="#ref-one">[1]</a></span><span class="reflittle"><a href="#ref-one-little">[1]</a></span>.
      </p>
     </div>
    </section>
    <section class="scrollspy" spy-title="Epidemiology">
      <div class="epi-section">
        <h2> Epidemiology</h2>
        <p>
          The frequency of SCA6 varies considerably according to geographical area. SCA6 represents only about 2 percent of the cases of dominant spinocerebellar ataxia in Italy, 31 percent in Japan, 1%-2% in Spain and France, 3% in China, 12% in the US and 13% in Germany <span class="refbig"><a href="#ref-two">[2]</a></span><span class="reflittle"><a href="#ref-two-little">[2]</a></span> (<a href="#epi-img">Figure 1</a>).
        </p>
        <p>
          According to <a href="https://www.ataxia.org/">National Ataxia Foundation</a>, in the United States, SCA6 represents about 15 percent of all cases of dominant hereditary ataxia. Overall, the prevalence of this disease is estimated at less than 1 in 100,000.
        </p>
        <p>
          Spinocerebellar ataxia type 6 (SCA6) estimated worldwide prevalence is less than 1/100,000, according to <a href="https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=98758">Orphanet</a>.
        </p>
        <input type="checkbox" id="zoomCheck">
        <label for="zoomCheck">
          <img id="epi-img" src="../../Images/original images/SCA6/SCA6_epi.png">
        </label>
      <figcaption> <strong>Figure 1:</strong> : Epidemiological features of spinocerebellar ataxia type 6 (SCA3). Relative frequency of SCA6 in the context of autosomal dominant cerebellar ataxias, around the world, according to Gene Reviews <span class="refbig"><a href="#ref-two">[2]</a></span><span class="reflittle"><a href="#ref-two-little">[2]</a></span>. Created with <a href="https://www.mapchart.net/">MapChart</a>.</figcaption>
        <a class="download-image" href="../../Images/original images/SCA6/SCA6_epi.png" download> [Fullsize image] </a>
      </div>
    </section>
    <section class="scrollspy" spy-title="Causative gene">
        <div class="gene-section">
          <h2>Causative gene</h2>
          <p>
            The gene affected in this disease is the CACNA1A. It has a size of 300kb with a minus strand orientation. This gene has 47 exons, according to many sources and the pathological CAG repeats are found in exon 47 (<a href="#gene-image1">Figure 2</a>). It is in chromosome 19 (cytogenic band: 19p13.13) and the gene translates to a calcium gated channel and another protein translated via cap-independent manner currently denominated as a1ACT (<a href="#gene-image2">Figure 3</a>).
          </p>
          <p>
            Normal length of the CAG repeat tract at the C-terminus of the a1A subunit of the P/Q-type voltage-gated calcium channel CACNA1A ranges between 4 and 18 glutamines. In SCA6 the tract is expanded to between 19 and 33 glutamines.
          </p>
          <div class="image-one">
            <img id="gene-image1" src="../../Images/original images/SCA6/CACNA1A.png" title="CACNA1A gene">
            <figcaption> <strong>Figure 2:</strong> ATXN3 gene. Created with <a href="https://biorender.com/"> BioRender.com</a></figcaption>
            <a class="download-image" target="_blank" href="../../Images/original images/SCA6/CACNA1A.png" download> [Fullsize image] </a>
          </div>
          <div class="image-two">
            <img id="gene-image2" src="../../Images/original images/SCA6/chromosome.png" title="CACNA1A gene chromosomal location">
            <figcaption> <strong>Figure 3:</strong> ATXN3 gene chromossomal localization. Created with <a href="https://biorender.com/"> BioRender.com</a></figcaption>
            <a class="download-image" target="_blank" href="../../Images/original images/SCA6/chromosome.png" download> [Fullsize image] </a>
          </div>
        </div>
    </section>
    <section class="scrollspy" spy-title="Codified protein">
      <div class="protein-section">
        <h2> Codified protein: structure, domains, functions and intracellular localization</h2>
        <h3>Structure and domains</h3>
        <p>
          CACNA1A gene codes for the voltage-dependent P/Q-type calcium channel subunit α1A. This channel has a length of 2506 aa and a mass of 282 564 Da (Isoform 1). This channel is mostly expressed in the brain (neuronal tissue) followed by the stomach and is involved in a variety of calcium-dependent processes.
        </p>
        <p>
          It is now known that the C-terminus of the a1A subunit (a1ACT) is physiologically formed from the mRNA of the full-length subunit <span class="refbig"><a href="#ref-three">[3]</a></span><span class="reflittle"><a href="#ref-three-little">[3]</a></span> and translocated to the nucleus and is directly involved in gene expression regulation.
        </p>
        <p>
           The voltage-dependent P/Q-type calcium channel subunit alpha-1A is represented in <a href="#protein-image">Figure 4</a> along with <a href="#table">Table 1</a> with information on each important domain/repeat (information from <a href="https://www.uniprot.org/">Uniprot.org</a>).
        </p>
        <div class="non-interactive">
          <img id="protein-image" src="../../Images/original images/SCA6/protein.png" title="Ataxin-2 structure">
          <figcaption> <strong>Figure 4: </strong> Voltage-dependent P/Q-type calcium channel subunit α1A protein representation. Created with <a href="https://biorender.com/"> BioRender.com</a></figcaption>
          <a class="download-image" target="_blank" href="../../Images/original images/SCA6/protein.png" download> [Fullsize image] </a>
        </div>
        <div class="table">
        <table style="width:100%" id="table">
          <caption>Table 1. &nbspVoltage-dependent P/Q-type calcium channel subunit alpha-1A important regions</caption>
          <tr>
            <th>Description</th>
            <th>Position</th>
            <th>Length</th>
          </tr>
          <tr>
            <td>I</td>
            <td>85-363</td>
            <td>279</td>
          </tr>
          <tr>
            <td>II</td>
            <td>472-716</td>
            <td>245</td>
          </tr>
          <tr>
            <td>III</td>
            <td>1230-1513</td>
            <td>284</td>
          </tr>
          <tr>
            <td>IV</td>
            <td>1550-1813</td>
            <td>264</td>
          </tr>
        </table>
        <div class="caption-under"> <strong>Table Caption:</strong>  Voltage-dependent P/Q-type calcium channel subunit alpha-1A important repeat/domain structures with respective positions, description and lenghts.</div>
      </div>
      <h3>Protein functions and biological role</h3>
      <p>
        Voltage-gated Ca2+ channels (VGCC) are of extreme importance because influx of Ca2+ through these channels regulate various cellular processes, including neurotransmission and gene expression <span class="refbig"><a href="#ref-four">[4]</a></span><span class="reflittle"><a href="#ref-four-little">[4]</a></span>:
      </p>
      <ul>
        <li>Involved in synaptic transmission and integration <span class="refbig"><a href="#ref-five">[5]</a></span><span class="reflittle"><a href="#ref-five-little">[5]</a></span>.</li>
        <li>Involved in gene regulation <span class="refbig"><a href="#ref-six">[6]</a></span><span class="reflittle"><a href="#ref-six-little">[6]</a></span>.</li>
        <li>Plays a crucial role in membrane excitability, triggering synaptic transmission and neuronal plasticity <span class="refbig"><a href="#ref-seven">[7]</a></span><span class="reflittle"><a href="#ref-seven-little">[7]</a></span>.</li>
      </ul>
      <p>
        The C-terminus of the α1A subunit (α1ACT) is the one more directly involved in gene expression and therefore the α1A subunit is often given the gene expression regulation function. This fragment is translated in a way termed: cap-independent, which occurs when the 40S ribosome directly binds mRNA near the start codon at an internal ribosome entry site (IRES) <span class="refbig"><a href="#ref-eight">[8]</a></span><span class="reflittle"><a href="#ref-eight-little">[8]</a></span>.Through an AT-rich element of α1ACT binding site, α1ACT is capable of:
      </p>
      <ul>
        <li>Binding genes expressed in the neurons.</li>
        <li>Regulating gene expression in neurons.</li>
      </ul>
      <p>
        As a transcription factor, the normal α1ACT enhances the expression of at least three genes, GRN, PMCA2 and BTG1, in PC12 cells and cerebellar tissue <span class="refbig"><a href="#ref-nine">[9]</a></span><span class="reflittle"><a href="#ref-nine-little">[9]</a></span>.
      </p>
      <h3> Protein intracellular localization</h3>
      <p>
        According to <a href="https://www.proteinatlas.org/ENSG00000141837-CACNA1A">Protein Atlas</a> and <a href="https://www.uniprot.org/uniprot/P97445">Uniprot</a>, this channel protein is mainly localized in cell membranes. Within neurons it can be found in the nucleus, plasma membrane (in the voltage-gated calcium channel complex) and other locations such as cell projections, cytoplasm and synapses.
      </p>
      <div class="interactive-image" id="my-interactive-image">
        <img src="../../Images/cell-scheme.jpg" />
      </div>
      <div class="int-caption"> <strong>Figure 5:</strong> Voltage-dependent P/Q-type calcium channel subunit alpha-1A and α1ACT localization.<br>(Refresh this element if changed resolutions &nbsp<a href="javascript:void(0)" onclick="window.location.reload();"><i class="fa-solid fa-arrows-rotate"></i></a>&nbsp)</div>
      </div>
    </section>
    <section class="scrollspy" spy-title="Pathophysiology">
      <div class="patho-section">
        <h2> Pathophysiology</h2>
        <p>
          The involvement of a functional ion channel subunit (α1A) of a voltage-gate calcium channel in SCA6 favours the hypothesis that SCA6 is an ion channel disorder in which the polyglutamine expansion in the C-terminus of the α1A subunit causes ataxia by altering calcium channel function. This theory had conflicting results and later had some evidence against it <span class="refbig"><a href="#ref-ten">[10]</a></span><span class="reflittle"><a href="#ref-ten-little">[10]</a></span>,
          <span class="refbig"><a href="#ref-eleven">[11]</a></span><span class="reflittle"><a href="#ref-eleven-little">[11]</a></span>.
        </p>
        <p>
          When it came to the C-terminus of the α1A subunit (α1ACT), there was an article on HEK cell cultures which presented that expressing C-termini containing Q28 were significantly more toxic than C-termini harbouring Q13 <span class="refbig"><a href="#ref-twelve">[12]</a></span><span class="reflittle"><a href="#ref-twelve-little">[12]</a></span>. This toxicity is independent of the function of the full-length protein. In addition, like other polyglutamine diseases the toxicity is highly dependent on the nuclear localization of the expanded protein.
        </p>
        <p>
          The α1ACT with polyglutamine expansion is found within cerebellar tissue and localizes to Purkinje cell nuclei, and that nuclear localization is not affected by polyglutamine length <span class="refbig"><a href="#ref-thirteen">[13]</a></span><span class="reflittle"><a href="#ref-thirteen-little">[13]</a></span>.
        </p>
        <p>
          Compared to the properties of the normal α1ACT protein, the α1ACT with expanded glutamines has altered binding to various regular targets affecting normal cell functioning <span class="refbig"><a href="#ref-nine">[9]</a></span><span class="reflittle"><a href="#ref-nine-little">[9]</a></span>.
        </p>
        <p>
          Formation of insoluble aggregates, or more direct interference by soluble forms of the mutant protein, with certain vital components of cellular metabolism or nuclear processes has been invoked as pathogenic mechanisms, but remains to be determined whether the accumulation of aggregates contributes to the pathogenesis or protection from the disease <span class="refbig"><a href="#ref-fourteen">[14]</a></span><span class="reflittle"><a href="#ref-fourteen-little">[14]</a></span>.
        </p>
      </div>
    </section>
    <section class="scrollspy" spy-title="Clinical Manifestations">
      <div class="clinical-section">
        <h2> Clinical manifestations: neuropathology, other signs and symptoms</h2>
        <h3>Neuropathology</h3>
        <p>
          The most common neuropathologic findings in individuals with SCA6 consist on either selective Purkinje cell degeneration or a combined degeneration of Purkinje cells and granule cells <span class="refbig"><a href="#ref-fifteen">[15]</a></span><span class="reflittle"><a href="#ref-fifteen-little">[15]</a></span>. Morphological changes in the few remaining Purkinje cells can be seen
          <span class="refbig"><a href="#ref-fifteen">[15]</a></span><span class="reflittle"><a href="#ref-fifteen-little">[15]</a></span>,
          <span class="refbig"><a href="#ref-sixteen">[16]</a></span><span class="reflittle"><a href="#ref-sixteen-little">[16]</a></span>, such as heterotopic nuclei, unclear cytoplasmic outline, somatic sprouts, dendritic swelling with increased numbers of spine-like protrusions and disorganization of axonal arrangements. In contrast to other SCAs, where cell loss and gliosis in additional regions can be seen secondary to the profound loss of Purkinje cells, very limited degeneration is detected in associated cortical or cerebello-olivary regions in SCA6
          <span class="refbig"><a href="#ref-fifteen">[15]</a></span><span class="reflittle"><a href="#ref-fifteen-little">[15]</a></span>,
          <span class="refbig"><a href="#ref-seventeen">[17]</a></span><span class="reflittle"><a href="#ref-seventeen-little">[17]</a></span>. Some decrease in the number of neurons in the inferior olivary nuclei may be detected when disease duration is long
          <span class="refbig"><a href="#ref-eighteen">[18]</a></span><span class="reflittle"><a href="#ref-eighteen-little">[18]</a></span>.
        </p>
        <h3> Signs and symptoms</h3>
        <p>
          Spinocerebellar ataxia type 6 (SCA6) is characterized by adult-onset, slowly progressive cerebellar ataxia. The age at which symptoms first occur varies widely, from age 19 to 71, but is typically between 43 and 52.
        </p>
        <div class="list-flex">
          <div class="column-one">
            <div class="column-one-title">
              <strong>Inital symptoms</strong>
            </div>
          <ul>
            <li>Gait unsteadiness</li>
            <li>Stumbling</li>
            <li>Imbalance</li>
            <li>Dysarthria</li>
          </ul>
          </div>
          <div class="column-two">
            <div class="column-two-title">
              <strong>As disease progresses</strong>
            </div>
          <ul>
            <li>Gait Ataxia</li>
            <li>Upper-limb incoordination</li>
            <li>Intention tremor</li>
          </ul>
          </div>
          <div class="column-three">
            <div class="column-three-title">
              <strong>Common symptoms</strong>
            </div>
          <ul>
            <li>Dysphagia</li>
            <li>Choking</li>
            <li>Oculomotor disorders</li>
            <li>Peripheral neuropathy</li>
          </ul>
          </div>
      </div>
      </div>
    </section>
    <section class="scrollspy" spy-title="References" id="references">
      <div class="reference-section">
        <h2> References </h2>
        <ol>
          <li><a id="ref-one-little" class="articlebottom">O. Zhuchenko et al., “Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel,” Nat. Genet., vol. 15, no. 1, pp. 62–69, Jan. 1997.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/8988170/" class="links">[PUBMED]</a><a href="https://www.nature.com/articles/ng0197-62" class="links">[Nature]</a></li>
          <li><a id="ref-two-little" class="articlebottom">H. L. Casey and C. M. Gomez, “Spinocerebellar Ataxia Type 6,” vol. 54, pp. 473–479, Nov. 2019, Accessed: Mar. 10, 2022.</a><br><a href="https://www.ncbi.nlm.nih.gov/books/NBK1140/" class="links">[NCBI Books]</a></li>
          <li><a id="ref-three-little" class="articlebottom">X. Du et al., “Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6,” Cell, vol. 154, no. 1, p. 118, Jul. 2013.</a><br><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939801/" class="links">[PUBMED Central - Full Text]</a><a href="https://www.cell.com/cell/fulltext/S0092-8674(13)00705-8" class="links">[Cell - Full Text]</a></li>
          <li><a id="ref-four-little" class="articlebottom">A. L. Goldin et al., “Nomenclature of voltage-gated sodium channels,” Neuron, vol. 28, no. 2, pp. 365–368, 2000.</a><br><a href="https://www.cell.com/neuron/fulltext/S0896-6273(00)00116-1" class="links">[Cell - Full Text]</a></li>
          <li><a id="ref-five-little" class="articlebottom">A. M. Dueñas, R. Goold, and P. Giunti, “Molecular pathogenesis of spinocerebellar ataxias,” Brain, vol. 129, no. Pt 6, pp. 1357–1370, 2006.</a><br><a href="https://academic.oup.com/brain/article/129/6/1357/297742" class="links">[Oxford Academic - Full Text]</a></li>
          <li><a id="ref-six-little" class="articlebottom">R. J. Miller, “Calcium channels prove to be a real headache,” Trends Neurosci., vol. 20, no. 5, pp. 189–192, May 1997.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/9141192/" class="links">[PUBMED]</a><a href="https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(96)01037-5" class="links">[Cell]</a></li>
          <li><a id="ref-seven-little" class="articlebottom">W. A. Catterall and A. P. Few, “Calcium channel regulation and presynaptic plasticity,” Neuron, vol. 59, no. 6, pp. 882–901, Sep. 2008.</a><br><a href="https://www.cell.com/neuron/fulltext/S0896-6273(08)00752-6" class="links">[Cell - Full Text]</a></li>
          <li><a id="ref-eight-little" class="articlebottom">J. Palmenberg A.C. and Sgro, “Topological organization of picornaviral genomes: statistical prediction of RNA structural signals.,” Semin. Virol., vol. 8, pp. 231–241, 1997.</a><br><a href="https://www.academia.edu/9767301/Topological_Organization_of_Picornaviral_Genomes_Statistical_Prediction_of_RNA_Structural_Signals" class="links">[PDF]</a></li>
          <li><a id="ref-nine-little" class="articlebottom">C. Matos, L. Pereira de Almeida, and C. Nóbrega, “Polyglutamine Disorders,” J. Neurochem., vol. 1049, no. September, pp. 155–162, 2018.</a><br><a href="https://link.springer.com/book/10.1007/978-3-319-71779-1" class="links">[Book]</a></li>
          <li><a id="ref-ten-little" class="articlebottom">K. Watase et al., “Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels,” Proc. Natl. Acad. Sci. U. S. A., vol. 105, no. 33, pp. 11987–11992, Aug. 2008.</a><br><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503926/" class="links">[PUBMED Central - Full Text]</a></li>
          <li><a id="ref-eleven-little" class="articlebottom">H. Saegusa et al., “Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells,” Mol. Cell. Neurosci., vol. 34, no. 2, pp. 261–270, Feb. 2007.</a><br><a href="https://www.sciencedirect.com/science/article/abs/pii/S1044743106002582?via%3Dihub" class="links">[ScienceDirect - Full Text]</a></li>
          <li><a id="ref-twelve-little" class="articlebottom">T. Kubodera et al., “Proteolytic cleavage and cellular toxicity of the human alpha1A calcium channel in spinocerebellar ataxia type 6,” Neurosci. Lett., vol. 341, no. 1, pp. 74–78, Apr. 2003.</a><br><a href="https://www.sciencedirect.com/science/article/abs/pii/S0304394003001563" class="links">[ScienceDirect]</a></li>
          <li><a id="ref-thirteen-little" class="articlebottom">H. B. Kordasiewicz, R. M. Thompson, H. B. Clark, and C. M. Gomez, “C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity,” Hum. Mol. Genet., vol. 15, no. 10, pp. 1587–1599, May 2006.</a><br><a href="https://academic.oup.com/hmg/article/15/10/1587/2355884" class="links">[Oxford Academic - Full Text]</a></li>
          <li><a id="ref-fourteen-little" class="articlebottom">R. E. Westenbroek et al., “Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels,” J. Neurosci., vol. 15, no. 10, pp. 6403–6418, 1995.</a><br><a href="https://www.jneurosci.org/content/15/10/6403" class="links">[JNeurosci]</a></li>
          <li><a id="ref-fifteen-little" class="articlebottom">C. M. Gomez et al., “Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset,” Ann. Neurol., vol. 42, no. 6, pp. 933–950, Dec. 1997.</a><br><a href="https://onlinelibrary.wiley.com/doi/10.1002/ana.410420616" class="links">[Wiley Online Library]</a></li>
          <li><a id="ref-sixteen-little" class="articlebottom">H. Sasaki et al., “Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6),” Acta Neuropathol., vol. 95, no. 2, pp. 199–204, 1998.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/9498057/" class="links">[PUBMED]</a><a href="https://link.springer.com/article/10.1007/s004010050787" class="links">[Springer]</a></li>
          <li><a id="ref-seventeen-little" class="articlebottom">K. K. Lau, K. M. Au, M. L. Chen, H. L. Li, B. Sheng, and A. Y. W. Chan, “Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations,” Neurology, vol. 49, no. 5, pp. 207–209, Jun. 1997.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/9371902/" class="links">[PUBMED]</a></li>
          <li><a id="ref-eighteen-little" class="articlebottom">K. Tsuchiya et al., “Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: report of two autopsy cases and statistical analysis of autopsy cases reported to date,” Neuropathology, vol. 25, no. 2, pp. 125–135, Jun. 2005.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/15875905/" class="links">[PUBMED]</a><a href="https://onlinelibrary.wiley.com/doi/10.1111/j.1440-1789.2005.00596.x" class="links">[Wiley Online Library]</a></li>
        </ol>
      </div>
    </section>
    </div>
    <div class="aside-bar-right" id="bar-right">
      <div class="ref-side-bar">
        <h3><i class="fa-solid fa-link"></i> References</h3>
        <ul>
          <li><a href="" id="ref-one" class="articlefocus">1. &nbsp O. Zhuchenko et al., “Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel,” Nat. Genet., vol. 15, no. 1, pp. 62–69, Jan. 1997.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/8988170/" class="links">[PUBMED]</a><a href="https://www.nature.com/articles/ng0197-62" class="links">[Nature]</a></li>
          <li><a href="" id="ref-two" class="articlefocus">2. &nbsp H. L. Casey and C. M. Gomez, “Spinocerebellar Ataxia Type 6,” vol. 54, pp. 473–479, Nov. 2019, Accessed: Mar. 10, 2022.</a><br><a href="https://www.ncbi.nlm.nih.gov/books/NBK1140/" class="links">[NCBI Books]</a></li>
          <li><a href="" id="ref-three" class="articlefocus">3. &nbsp X. Du et al., “Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6,” Cell, vol. 154, no. 1, p. 118, Jul. 2013.</a><br><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939801/" class="links">[PUBMED Central - Full Text]</a><a href="https://www.cell.com/cell/fulltext/S0092-8674(13)00705-8" class="links">[Cell - Full Text]</a></li>
          <li><a href="" id="ref-four" class="articlefocus">4. &nbsp A. L. Goldin et al., “Nomenclature of voltage-gated sodium channels,” Neuron, vol. 28, no. 2, pp. 365–368, 2000.</a><br><a href="https://www.cell.com/neuron/fulltext/S0896-6273(00)00116-1" class="links">[Cell - Full Text]</a></li>
          <li><a href="" id="ref-five" class="articlefocus">5. &nbsp A. M. Dueñas, R. Goold, and P. Giunti, “Molecular pathogenesis of spinocerebellar ataxias,” Brain, vol. 129, no. Pt 6, pp. 1357–1370, 2006.</a><br><a href="https://academic.oup.com/brain/article/129/6/1357/297742" class="links">[Oxford Academic - Full Text]</a></li>
          <li><a href="" id="ref-six" class="articlefocus">6. &nbsp R. J. Miller, “Calcium channels prove to be a real headache,” Trends Neurosci., vol. 20, no. 5, pp. 189–192, May 1997.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/9141192/" class="links">[PUBMED]</a><a href="https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(96)01037-5" class="links">[Cell]</a></li>
          <li><a href="" id="ref-seven" class="articlefocus">7. &nbsp W. A. Catterall and A. P. Few, “Calcium channel regulation and presynaptic plasticity,” Neuron, vol. 59, no. 6, pp. 882–901, Sep. 2008.</a><br><a href="https://www.cell.com/neuron/fulltext/S0896-6273(08)00752-6" class="links">[Cell - Full Text]</a></li>
          <li><a href="" id="ref-eight" class="articlefocus">8. &nbsp J. Palmenberg A.C. and Sgro, “Topological organization of picornaviral genomes: statistical prediction of RNA structural signals.,” Semin. Virol., vol. 8, pp. 231–241, 1997.</a><br><a href="https://www.academia.edu/9767301/Topological_Organization_of_Picornaviral_Genomes_Statistical_Prediction_of_RNA_Structural_Signals" class="links">[PDF]</a></li>
          <li><a href="" id="ref-nine" class="articlefocus">9. &nbsp C. Matos, L. Pereira de Almeida, and C. Nóbrega, “Polyglutamine Disorders,” J. Neurochem., vol. 1049, no. September, pp. 155–162, 2018.</a><br><a href="https://link.springer.com/book/10.1007/978-3-319-71779-1" class="links">[Book]</a></li>
          <li><a href="" id="ref-ten" class="articlefocus">10. &nbsp K. Watase et al., “Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels,” Proc. Natl. Acad. Sci. U. S. A., vol. 105, no. 33, pp. 11987–11992, Aug. 2008.</a><br><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503926/" class="links">[PUBMED Central - Full Text]</a></li>
          <li><a href="" id="ref-eleven" class="articlefocus">11. &nbsp H. Saegusa et al., “Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells,” Mol. Cell. Neurosci., vol. 34, no. 2, pp. 261–270, Feb. 2007.</a><br><a href="https://www.sciencedirect.com/science/article/abs/pii/S1044743106002582?via%3Dihub" class="links">[ScienceDirect - Full Text]</a></li>
          <li><a href="" id="ref-twelve" class="articlefocus">12. &nbsp T. Kubodera et al., “Proteolytic cleavage and cellular toxicity of the human alpha1A calcium channel in spinocerebellar ataxia type 6,” Neurosci. Lett., vol. 341, no. 1, pp. 74–78, Apr. 2003.</a><br><a href="https://www.sciencedirect.com/science/article/abs/pii/S0304394003001563" class="links">[ScienceDirect]</a></li>
          <li><a href="" id="ref-thirteen" class="articlefocus">13. &nbsp H. B. Kordasiewicz, R. M. Thompson, H. B. Clark, and C. M. Gomez, “C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity,” Hum. Mol. Genet., vol. 15, no. 10, pp. 1587–1599, May 2006.</a><br><a href="https://academic.oup.com/hmg/article/15/10/1587/2355884" class="links">[Oxford Academic - Full Text]</a></li>
          <li><a href="" id="ref-fourteen" class="articlefocus">14. &nbsp R. E. Westenbroek et al., “Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels,” J. Neurosci., vol. 15, no. 10, pp. 6403–6418, 1995.</a><br><a href="https://www.jneurosci.org/content/15/10/6403" class="links">[JNeurosci]</a></li>
          <li><a href="" id="ref-fifteen" class="articlefocus">15. &nbsp C. M. Gomez et al., “Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset,” Ann. Neurol., vol. 42, no. 6, pp. 933–950, Dec. 1997.</a><br><a href="https://onlinelibrary.wiley.com/doi/10.1002/ana.410420616" class="links">[Wiley Online Library]</a></li>
          <li><a href="" id="ref-sixteen" class="articlefocus">16. &nbsp H. Sasaki et al., “Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6),” Acta Neuropathol., vol. 95, no. 2, pp. 199–204, 1998.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/9498057/" class="links">[PUBMED]</a><a href="https://link.springer.com/article/10.1007/s004010050787" class="links">[Springer]</a></li>
          <li><a href="" id="ref-seventeen" class="articlefocus">17. &nbsp K. K. Lau, K. M. Au, M. L. Chen, H. L. Li, B. Sheng, and A. Y. W. Chan, “Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations,” Neurology, vol. 49, no. 5, pp. 207–209, Jun. 1997.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/9371902/" class="links">[PUBMED]</a></li>
          <li><a href="" id="ref-eighteen" class="articlefocus">18. &nbsp K. Tsuchiya et al., “Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: report of two autopsy cases and statistical analysis of autopsy cases reported to date,” Neuropathology, vol. 25, no. 2, pp. 125–135, Jun. 2005.</a><br><a href="https://pubmed.ncbi.nlm.nih.gov/15875905/" class="links">[PUBMED]</a><a href="https://onlinelibrary.wiley.com/doi/10.1111/j.1440-1789.2005.00596.x" class="links">[Wiley Online Library]</a></li>
        </ul>
      </div>
    </div>
  </main>
  <footer id=footer>
    <div class="collumns">
      <div class="first-third">
        <ul>
          <li><a href="">Contact</a></li>
          <li><a href="">ABCRI</a></li>
          <li><a href="">MNGT</a></li>
          <li><a href="">News</a></li>
        </ul>
      </div>
      <div class="second-third">
        <ul>
          <li><a href="">Authors</a></li>
          <li><a href="">Sources</a></li>
          <li><a href="">UALG</a></li>
          <li><a href="">Masters</a></li>
        </ul>
      </div>
      <div class="third-third">
        <ul>
          <li><a href="">Help</a></li>
          <li><a href="">Affiliations</a></li>
          <li><a href="">Thanks for visiting!</a></li>
        </ul>
      </div>
    </div>
    <svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="200.000000pt" height="200.000000pt" viewBox="0 0 200.000000 200.000000" preserveAspectRatio="xMidYMid meet">
<metadata>
Created by potrace 1.10, written by Peter Selinger 2001-2011
</metadata>
<g transform="translate(0.000000,200.000000) scale(0.100000,-0.100000)" fill="#3d85c6" stroke="none">
<path d="M1514 1622 c-11 -10 -31 -22 -44 -25 -38 -10 -45 -17 -84 -82 -40 -67 -44 -94 -20 -135 18 -29 101 -80 132 -80 10 0 23 -5 29 -11 6 -6 26 -14 43 -18 24 -4 38 -16 51 -40 10 -19 23 -39 28 -44 14 -14 61 19 61 43 0 12 10 25 23 30 36 15 78 65 89 107 20 79 20 89 -8 152 -25 55 -33 64 -83 90 -72 36 -185 42 -217 13z m76 -27 c-10 -12 -10 -19 -2 -27 9 -9 18 -4 37 16 14 15 28 25 33 23 4 -2 25 -12 47 -22 40 -18 75 -43 75 -54 0 -9 -67 -7 -76 2 -12 12 -44 8 -44 -5 0 -20 48 -38 81 -31 49 9 81 -33 63 -81 -7 -19 -36 -21 -65 -3 -17 9 -23 9 -26 0 -3 -8 -14 -11 -28 -7 -12 3 -26 1 -30 -5 -3 -6 -17 -8 -31 -5 -13 3 -24 2 -24 -4 0 -19 -33 -22 -57 -6 -35 22 -52 3 -23 -24 21 -20 21 -20 2 -26 -23 -8 -117 37 -126 60 -9 24 -7 74 3 74 5 0 11 -7 15 -15 9 -26 48 -17 77 18 21 24 28 28 29 15 0 -24 22 -23 38 2 7 11 21 20 31 20 11 0 22 4 26 9 10 17 -15 23 -68 16 -38 -6 -58 -15 -78 -37 -25 -26 -29 -27 -37 -11 -19 32 20 83 64 83 8 0 23 9 34 20 11 11 32 20 46 20 23 0 25 -2 14 -15z m179 -224 l34 -1 -23 -25 c-25 -26 -59 -32 -91 -15 -15 8 -24 6 -41 -10 -13 -11 -35 -20 -54 -20 -60 0 -53 30 11 50 22 7 46 15 53 19 8 3 28 5 45 5 18 -1 47 -2 66 -3z m-34 -81 c-3 -5 -12 -10 -20 -10 -8 0 -17 5 -20 10 -4 6 5 10 20 10 15 0 24 -4 20 -10z m-61 -22 c14 -55 0 -64 -26 -19 -12 22 -13 31 -5 35 21 8 25 6 31 -16z"/>
<path d="M72 1198 c-23 -23 -14 -59 18 -71 l30 -11 0 -163 c0 -150 -1 -163 -18 -163 -37 0 -57 -51 -30 -78 15 -15 100 -15 152 -1 60 16 158 119 182 189 32 94 68 153 113 187 23 18 48 33 54 33 9 0 12 -46 12 -165 0 -91 -1 -165 -2 -165 -1 0 -13 5 -27 11 -25 12 -25 14 -28 142 l-3 130 -29 -41 c-25 -37 -28 -48 -24 -102 4 -63 -4 -78 -19 -34 -9 26 -10 26 -36 -27 l-26 -54 31 -33 c81 -83 206 -106 306 -56 81 40 129 104 177 238 20 54 73 119 117 142 l28 15 0 -166 0 -165 -22 11 c-22 10 -23 13 -20 139 3 142 -1 151 -48 88 -19 -26 -22 -40 -18 -94 2 -35 3 -64 1 -64 -1 0 -8 12 -16 26 l-14 26 -26 -53 -26 -54 32 -34 c92 -97 257 -108 353 -24 44 39 93 115 114 177 27 82 69 140 120 166 l40 20 0 -164 0 -165 -22 8 c-22 8 -23 15 -28 137 l-5 128 -29 -34 c-26 -31 -28 -39 -24 -97 4 -66 -4 -82 -19 -37 -9 26 -10 26 -36 -27 l-26 -54 32 -33 c52 -55 116 -82 191 -82 56 0 67 3 76 21 9 16 8 26 -5 45 -8 13 -22 24 -30 24 -13 0 -15 26 -15 164 0 152 1 164 19 169 31 8 43 40 25 65 -13 18 -25 22 -72 22 -131 0 -232 -90 -286 -256 -19 -57 -73 -127 -117 -149 -15 -8 -30 -15 -34 -15 -3 0 -5 74 -5 165 0 91 3 165 6 165 3 0 14 -5 25 -10 17 -10 19 -22 19 -143 l0 -132 28 28 c23 24 28 37 32 105 6 73 6 75 18 48 l13 -30 25 54 25 53 -38 39 c-54 55 -107 78 -181 78 -112 0 -206 -69 -259 -188 -13 -31 -34 -78 -45 -104 -21 -48 -51 -82 -100 -113 l-28 -17 0 166 c0 164 0 167 20 156 18 -10 20 -21 20 -143 l1 -132 36 39 c35 38 35 39 29 102 -7 69 -2 81 15 37 l11 -28 23 45 c32 61 31 73 -12 110 -114 100 -276 92 -375 -18 -42 -47 -63 -83 -89 -159 -10 -30 -28 -67 -40 -84 -22 -31 -94 -89 -111 -89 -4 0 -8 74 -8 165 0 91 3 165 6 165 3 0 14 -5 25 -10 17 -10 19 -23 19 -143 l1 -132 29 34 c25 30 30 44 32 105 3 68 4 70 17 44 l14 -27 23 50 c22 46 22 52 8 74 -17 27 -76 69 -117 84 -38 15 -140 14 -155 -1z m153 -22 c19 -8 51 -27 70 -42 50 -38 44 -69 -17 -88 -15 -4 -18 -17 -18 -71 0 -37 -4 -64 -9 -61 -5 3 -9 41 -9 83 0 43 -1 86 -1 95 -1 25 -58 53 -77 37 -19 -15 -21 -318 -2 -337 24 -24 57 -12 107 36 37 36 56 66 81 130 18 46 46 101 62 123 36 49 111 106 117 87 2 -7 10 -21 19 -30 14 -16 13 -18 -6 -18 -48 0 -103 -73 -151 -199 -26 -69 -84 -143 -133 -171 -48 -27 -161 -40 -173 -20 -5 9 3 22 24 39 l31 26 0 160 0 160 -31 26 c-19 15 -29 31 -25 37 10 17 100 15 141 -2z m487 -12 c18 -9 47 -30 65 -47 26 -24 30 -34 22 -49 -5 -10 -21 -18 -34 -18 -27 0 -33 -13 -38 -95 -2 -27 -4 -8 -5 44 -2 82 -5 98 -24 118 -25 27 -41 29 -62 7 -23 -23 -23 -315 0 -338 20 -20 20 -20 69 8 51 30 85 78 124 174 37 92 62 129 115 168 54 41 108 58 162 50 86 -11 172 -74 159 -116 -4 -13 -13 -20 -24 -18 -10 2 -25 -3 -34 -11 -15 -12 -17 -10 -17 22 0 27 -7 41 -27 57 -32 25 -54 23 -68 -6 -10 -21 -10 -21 -28 3 -22 28 -45 24 -91 -14 -46 -38 -81 -93 -106 -164 -41 -119 -116 -192 -215 -210 -87 -16 -126 9 -70 45 25 16 25 17 25 180 l0 164 -27 20 c-18 13 -24 24 -20 36 6 15 16 17 62 12 30 -3 70 -13 87 -22z m898 10 c2 -3 -9 -16 -25 -28 -30 -23 -30 -26 -33 -127 -2 -57 -5 -106 -8 -108 -2 -2 -4 43 -4 101 0 123 -9 139 -60 118 -46 -19 -112 -99 -134 -161 -25 -72 -68 -148 -103 -181 -85 -81 -235 -83 -312 -4 -25 25 -31 39 -26 55 3 12 14 21 24 21 28 0 41 21 43 70 1 26 4 11 7 -39 6 -77 8 -86 33 -104 27 -20 28 -20 48 -2 18 16 20 32 22 159 l2 141 6 -149 c6 -178 11 -185 85 -142 52 31 95 91 121 170 49 145 154 231 269 219 22 -3 42 -7 45 -9z m-1072 -380 c20 -10 21 -13 7 -24 -8 -7 -15 -19 -15 -27 0 -11 -6 -11 -30 4 -17 10 -42 30 -56 44 -22 23 -23 29 -13 52 7 15 17 23 25 20 28 -11 44 18 46 81 1 46 3 37 7 -39 6 -91 8 -100 29 -111z m912 44 c0 -55 51 -88 80 -53 11 13 16 12 41 -8 50 -39 30 -62 -44 -51 -51 8 -102 34 -139 69 -23 21 -26 29 -16 44 6 11 19 16 29 14 11 -3 21 1 25 11 9 24 24 9 24 -26z"/>
<path d="M470 550 c0 -65 3 -90 13 -90 9 0 11 23 9 90 -2 49 -8 90 -13 90 -5 0 -9 -40 -9 -90z"/>
<path d="M1090 551 l0 -89 33 1 c31 2 32 3 35 55 3 56 -10 85 -34 75 -10 -4 -14 2 -14 21 0 14 -4 26 -10 26 -6 0 -10 -36 -10 -89z m48 -27 c-2 -22 -7 -39 -13 -39 -12 0 -19 60 -10 83 10 28 27 -3 23 -44z"/>
<path d="M280 545 c0 -69 3 -85 15 -85 9 0 15 9 15 25 0 15 6 25 15 25 19 0 35 31 35 69 0 32 -22 51 -59 51 -20 0 -21 -6 -21 -85z m50 19 c0 -19 -4 -34 -10 -34 -5 0 -10 18 -10 41 0 24 4 38 10 34 6 -3 10 -22 10 -41z"/>
<path d="M612 618 c-7 -7 -12 -38 -12 -70 0 -45 5 -66 22 -88 21 -29 58 -41 58 -20 0 6 -7 10 -17 10 -15 0 -15 1 0 18 12 13 17 37 17 78 0 61 -11 84 -40 84 -9 0 -21 -5 -28 -12z m46 -85 c-5 -72 -28 -68 -28 5 0 32 3 62 7 66 13 13 24 -24 21 -71z"/>
<path d="M750 545 c0 -83 0 -85 24 -85 39 0 56 25 56 84 0 58 -19 86 -58 86 -21 0 -22 -4 -22 -85z m45 0 c0 -38 -4 -60 -12 -62 -10 -4 -13 13 -13 62 0 49 3 66 13 63 8 -3 12 -25 12 -63z"/>
<path d="M939 608 c-3 -53 3 -134 11 -142 5 -5 17 -5 27 -1 17 8 17 8 1 12 -25 6 -26 91 -2 100 15 6 15 7 -1 19 -9 7 -14 17 -10 23 3 6 -1 11 -9 11 -10 0 -17 -9 -17 -22z"/>
<path d="M392 591 c-19 -11 -27 -83 -13 -110 15 -26 47 -27 61 -2 15 29 12 87 -6 105 -18 18 -24 19 -42 7z m28 -61 c0 -27 -4 -50 -10 -50 -5 0 -10 23 -10 50 0 28 5 50 10 50 6 0 10 -22 10 -50z"/>
<path d="M510 588 c0 -7 7 -40 15 -73 12 -52 12 -61 0 -71 -20 -15 -19 -24 5 -24 19 0 28 22 45 110 4 19 9 43 11 53 4 11 0 17 -10 17 -11 0 -16 -9 -16 -29 0 -16 -3 -38 -7 -48 -6 -13 -9 -6 -13 26 -3 25 -11 46 -17 49 -7 2 -13 -2 -13 -10z"/>
<path d="M852 588 c-13 -13 -16 -38 -6 -38 4 0 13 8 20 18 12 16 13 16 20 -2 5 -13 3 -21 -4 -24 -24 -8 -43 -35 -40 -56 2 -16 11 -21 36 -23 l32 -1 0 63 c0 48 -4 64 -16 69 -22 8 -28 8 -42 -6z m38 -88 c0 -19 -11 -26 -23 -14 -8 8 3 34 14 34 5 0 9 -9 9 -20z"/>
<path d="M1006 584 c-20 -20 -20 -34 -1 -34 8 0 15 7 15 15 0 8 5 15 10 15 19 0 10 -31 -16 -54 -37 -31 -26 -66 20 -66 l33 0 -4 58 c-3 31 -6 63 -8 70 -6 17 -30 15 -49 -4z m34 -84 c0 -11 -4 -20 -10 -20 -5 0 -10 9 -10 20 0 11 5 20 10 20 6 0 10 -9 10 -20z"/>
<path d="M1193 593 c-13 -5 -18 -43 -7 -43 4 0 13 8 20 18 12 16 13 16 14 0 0 -9 -11 -29 -25 -42 -33 -33 -21 -65 25 -64 30 1 30 2 30 58 0 69 -16 90 -57 73z m23 -110 c-11 -11 -19 6 -11 24 8 17 8 17 12 0 3 -10 2 -21 -1 -24z"/>
<path d="M1271 581 c-8 -15 -5 -27 15 -56 25 -37 26 -65 0 -30 -9 13 -15 15 -20 6 -11 -17 14 -42 38 -39 29 4 32 35 7 69 -12 15 -21 34 -21 41 1 8 5 7 14 -4 17 -23 26 -23 26 1 0 17 -18 31 -40 31 -5 0 -14 -9 -19 -19z"/>
<path d="M1362 588 c-7 -7 -12 -36 -12 -65 0 -57 17 -76 48 -56 22 13 27 33 8 33 -9 0 -16 -4 -16 -10 0 -5 -4 -10 -10 -10 -5 0 -10 9 -10 20 0 15 7 20 25 20 21 0 25 5 25 28 0 29 -16 52 -35 52 -6 0 -16 -5 -23 -12z m38 -40 c0 -5 -7 -8 -15 -8 -15 0 -20 21 -8 33 7 7 23 -11 23 -25z"/>
</g>
</svg>
    <p> &copyPolyQ Database. All rights reserved 2021-2022. Authors mentioned and database creators all accounted for.</p>
    <div class="logos">
      <a class="logo-one" href=""> <img src="../../Images/Logo_ABCRI.png" alt=""></a>
      <a class="logo-two" href=""> <img src="../../Images/Logo_MNGT.png" alt=""></a>
      <a class="logo-three" href=""> <img src="../../Images/fmcb-mod.png" alt=""></a>
    </div>
  </footer>
  <script src="../../Scripts/jquery-3.6.0.min.js"></script>
  <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/interactiveimagejs@2.7.1/dist/interactive-image.min.js"></script>
  <script src="../../Scripts/Image-Int-Scripts/image-int-sca6.js"></script>
  <script>
            var indicator = document.getElementById('indicator');

            var spy = new ScrollSpy(
                {
                    contexts_class: 'scrollspy'
                }
            );

            spy.Indicator({
                element: indicator
            });
</script>
<script>
/* When the user clicks on the button,
toggle between hiding and showing the dropdown content */
function myFunction() {
  document.getElementById("myDropdown").classList.toggle("show");
}

function myFunctionLittle() {
  document.getElementById("myDropdownLittle").classList.toggle("show");
}

// Close the dropdown if the user clicks outside of it
window.onclick = function(event) {
  if (!event.target.matches('.dropbtn')) {
    var dropdowns = document.getElementsByClassName("dropdown-content");
    var i;
    for (i = 0; i < dropdowns.length; i++) {
      var openDropdown = dropdowns[i];
      if (openDropdown.classList.contains('show')) {
        openDropdown.classList.remove('show');
      }
    }
  }
  if (!event.target.matches('.dropbtn-little')){
    var dropLittle = document.getElementsByClassName("dropdown-content-little");
    var r;
    for (r = 0; r < dropLittle.length; r++) {
      var openDropLittle = dropLittle[r];
      if (openDropLittle.classList.contains('show')) {
        openDropLittle.classList.remove('show');
      }
    }
  }
}

</script>
<script>


$(document).scroll(function() {
    checkOffset();
});

function checkOffset() {
    if($('#bar-right').offset().top + $('#bar-right').height() >= $('#references').offset().top + 200)
          $('#bar-right').hide(800);
    if($(document).scrollTop() + window.innerHeight < $('#references').offset().top + 200)
          $('#bar-right').show(800); // restore when you scroll up
}
</script>
<script>

function reload(){
  var imageInt = document.getElementById("my-interactive-image");
  var imageContent = imageInt.innerHTML;
  imageInt.innerHTML = imageContent;
}

</script>


</body>


</html>
